College of Chicago. In the middle of his medical training, he found it necessary to go to work to finance his way through school. During this seven year interim he served as bacteriologist, sanitary chemist and assistant laboratory director of the Chicago Board of Health. After graduation in 1921, he was appointed Director of Laboratories and Research at the City of Chicago Municipal Tuberculosis Sanitarium where he remained for twenty-nine years. In 1950, he was appointed Chief Medical Director, Florida Tuberculosis Board, during the organization, building and staffing of three new hospitals, as well as establishing a treatment and research program. In 1955, he was appointed Director of Research, Pathology and Allied Sciences of the Missouri State Sanatorium, Mt. Vernon, Missouri. The high point in his experience was at the Chicago Municipal Tuberculosis Sanitarium where he went to work to serve a few months but remained for over twenty-nine years. The need in the field was so great and the opportunity so compelling that he decided to remain and try to roll back the fog of ignor.
No specific reimbursement for drugs as included in drg and global budget for public hospitals or polyclinics, for example, hcl.
PRENAFORT .73 prenatal.73 prenatal w folic acid.73 PRENATE ELITE .73 PREPIDIL .62 PREVACID.54 PREVACID IV .54 PREVACID NAPRAPAC .55 PREVIDENT.47 PREVNAR .57 PREVPAC.52 PRIFTIN.13 PRILOSEC .54 PRIMACARE.73 PRIMACARE ONE .73 PRIMAQUINE .12 PRIMAXIN .14 PRIMAXIN I.M 14 PRIMAXIN I.V.14 PRIMSOL.15 PRO-BANTHINE.52 probenecid .60 procainamide HCl .29 PROCALAMINE .74 PROCANBID .29 prochlorperazine.53 prochlorperazine isopropamide.52 PROCRIT .57 PROCTOFOAM-HC .56 PROCTO-KIT .56 proctozone-HC .56 progesterone in oil.62 PROGLYCEM .50 PROGRAF.21 PROLASTIN .45 PROLEUKIN .58 promethazine HCl.67 PROMETRIUM .62 PRONESTYL .29 propafenone HCl .29 propantheline bromide .52 proparacaine-fluorescein.64 propoxyphene HCl.23 propoxyphene HCl w apap.23 propranolol HCl .30 propranolol HCl w hctz.32 propylthiouracil .49 PROSCAR.69 PROSED EC.69 PROSOL.74 PROSTIGMIN.25 PROSTIN E2 VAGINAL SUPPOSITORY .62 protamine sulfate.31 PROTONIX .54.
SEQUENCE ANALYSIS OF -THALASSEMIA VARIANTS IN GREECE Georgiou I.1, Bouba I.1, Hatzi E.1, Pavlou E.2, Anagnostou G.2, Bourantas K.3, Kleanthous M.2 Genetics and IVF unit, Department of Obstetrics and Gynecology, Medical school, University of Ioannina, Greece 2 The Cyprus Institute of Neurology & Genetics, Nicosia, Cyprus 3 Department of Hematology, Medical school, University of Ioannina, Greece Several variants of the -chain resulting from amino acid substitutions have been described.The mutations causing -thalassemia have not been completely characterised. Several are not easily detectable by electrophoresis, but detected by either HPLC analysis or by sequencing of the -globin gene.The combination of molecular and biochemical procedures is important in the identification of the -chain abnormalities. During routine population screening by HPLC and other methods we have identified two individuals having abnormal Hb variants and one having no detectable HbA2 levels. The variants were eluted after the normal HbA2 with levels lower than 1.5%. In an attempt to identify these abnormal hemoglobins, we amplified the -globin gene by polymerase chain reaction PCR ; and determined the DNA sequence using automated fluorescence-based sequencer. Sequence analysis of the -globin gene revealed that these hemoglobin variants were the HbA2-Sphakia and HbA2-NYU. This is the first time that the actual sequence of HbA2- Sphakia CATCGT ; and HbA2-NYU AATAAG ; has been identified, since until now the sequence of these haemoglobin variants was predicted according to the amino acid sequence CACCGC and AATAAA respectively ; . The 0-thalassemia homozygote had undetectable HbA2 levels and her parents had very low levels of HbA2 below 1.5%. Both the affected and her parents had not any significant hematologic phenotype, for example, propafenone hcl.
It is important to check with your doctor before combining cymbalta with the following: flecainide tambocor ; propafenone rythmol ; amitriptyline elavil ; imipramine tofranil ; doxepin sinequan ; nortriptyline pamelor ; venlafaxine effexor ; chlorpromazine thorazine ; fluphenazine prolixin ; mesoridazine serentil ; perphenazine trilafon ; prochlorperazine compazine ; trovafloxacin trovan ; ciprofloxacin cipro ; ofloxacin floxin ; prozac, sarafem, paxil, pexeva, fluvoxamine luvox ; , and others order now to get off cymbalta.
Ic propafenone hcl
Clostridium, Corynebacterium, and Listeria species. Species of the Streptococcus, Staphylococcus, and Enterococcus genera have become more problematic throughout the past 20 years. Species of these genera, more than the other gram-positive species, have developed resistance to several antibiotic drugs through various mechanisms. Resistance by these species is particularly worrisome because of the increased frequency of involvement of these pathogens in infections. Streptococcus pneumoniae is the most common pathogen in communityacquired pneumonia CAP ; , sinusitis, otitis media, and meningitis. Enterococcus and Staphylococcus species are among the most common pathogens in nosocomial bloodstream, wound, and intravascular catheter-related infections. Furthermore, infections caused by antibioticresistant pathogens compared to antibiotic-susceptible isolates of the same species result in higher use of medical care, prolonged hospital stays, and increased mortality. In an intensive care unit population, mortality was twice as high when antibiotic drugs lacking in vitro activity were administered compared with antimicrobial drugs with activity against the offending organism. Antimicrobial efficacy is assessed differently from drugs used to treat other disease states. It would be expected that insulin will be as active at lowering blood sugar in a patient with diabetes in 50 years as it is today. In the future, there may be more effective drugs for treating patients with diabetes, but insulin would still be an option. This is not true for antibiotic drugs. Antimicrobial drugs used today may have reduced potency or no effect in the future. Through evolution, microorganisms have developed several methods to protect themselves against the increasing armamentarium of new antibiotic drugs. It also has become apparent that when an antimicrobial drug is discovered, some microbes develop the ability to survive doses of that drug that were initially lethal. Gram-positive Infections and rythmol.
Of behavior change or modification that slowly retrains the brain. Like people with diabetes or heart disease, people in treatment for drug addiction learn behavioral changes and often take medications as part of their treatment regimen." Did you know that over 60% of the young people currently in treatment are there for dependence on marijuana? When using illegal drugs, or abusing other substances such as inhalants, prescription drugs, or over the counter medications, there is a tremendous potential for addiction, and treatment may be the only option. Drug treatment is available to those who need help, including in-patient and out-patient centers, therapeutic communities and 12step programs. In addition to medical treatment programs, some are faith-based. Additionally, community programs such as Drug Courts give non-violent drug users in the criminal justice system opportunities for treatment--with conditions--instead of jail time. For more information on drug treatment, go to the Center for Substance Abuse Treatment CSAT ; at samhsa csat.gov. Drug Court information is available at nadcp . There are also many stories on the internet about teens seeking drug treatment. For information on how to help someone who needs treatment, go to the National Youth Anti-Drug Media Campaign at mediacampaign.
Coastal Agriculture and Fisheries Research and Development Bureau farm registrations , monitoring of water quality , antibiotic residues , raw material residues. ; Feed Research and Center Institute feed control ; Coastal Aquaculture Health Research Institute control uses of antibiotics ; Fish Inspection and Quality Control Division inspection of processing plants , pre-shipment inspection of finished products and pyrazinamide, for example, digoxin.
Propafenone tablets
This is the real crisis of health care today, not the cost, but the sham that passes for “ healing”.
In the right way. Tensions always arise inside organizations and between them, because the most comprehensive of agreements cannot possibly cover every eventuality. A person working in one organization usually cannot see what kind of pressures are building up behind their contact inside the partner organization. People generally try to optimize their own areas of responsibility and do not think about the whole picture. If someone succeeds in doing this too well, the collective effort as a whole suffers. We strive for a dynamic balance, but if it cannot be achieved in one particular project, then it will be in some other one. You have to believe that. Mutual trust is perhaps the most important success factor. Agreements have to be continuously fine-tuned because changes demand appropriate reactions. Groups have also learned to bring potential problems to those responsible for alliance management so that they can be resolved before they get out of hand. We put the problem on the table and say to those concerned, "Thanks for bringing this to our attention. Leave this with us, we'll sort it out while you get back to work." This approach saves an enormous amount of time and energy and quetiapine.
Prices used in this study include wholesale and retail mark-ups where applicable ; , and exclude dispensing fees. To measure generic and brand name price ratios, information on prices, quantities and total expenditures, were obtained from five provincial drug plans: British Columbia, Alberta, Saskatchewan, Manitoba and Ontario. Nova Scotia was omitted from this analysis due to the limited size of its data base.3 Health Canada's Drug Product Database was used to ensure that only those drugs defined by the Food and Drug Act were included. The analysis covers the period 1990 to 1997 and is organized in the following manner: Section 3 reports on the growth of generic market shares in each provincial drug plan; Section 4 presents the trend in generic-to-brand name price ratios for each provincial drug plan; Section 5 examines the impact on generic-to-brand name price ratios from the introduction of new generic drugs; and, Section 6 examines the effect on generic-to-brand name price ratios from the level of competition in a given market, i.e., the number of generic drugs available in a given market. A summary is provided in Section 7.
| Propafenone drug interactionsRimantadine hydrochloride is metabolized extensively in the liver to at least 3 hydroxylated metabolites. These have been designated as conjugated and unconjugated 3-, 4-, and 4-hydroxylated metabolites. A glucuronide conjugate of rimantadine also has been identified. In healthy adults, about 74% of a single 200-mg oral dose was excreted in urine within 72 hours as metabolites and unchanged drug. Less than 25% of an oral dose reportedly is excreted in urine unchanged. Following oral administration, the plasma elimination half-life of rimantadine averages 2538 hours in children and adults with normal renal and hepatic function. While the plasma elimination half-life in individuals with chronic liver disease i.e., stabilized cirrhosis ; is not prolonged compared with healthy individuals, the plasma elimination half-life in those with severe liver disease is prolonged 1.6-fold and the apparent clearance is 50% lower compared with healthy individuals. The plasma elimination half-life was increased 1.6-fold 44 versus 28 hours ; and apparent clearance decreased 40% in individuals with end-stage renal failure creatinine clearance 010 mL minute ; compared with healthy individuals. In one study in patients with a creatinine clearance of 31 50 1130 mL minute who received a single 200-mg dose of rimantadine hydrochloride, apparent clearance was reduced 37 or 16%, respectively, and plasma metabolite concentrations were higher than in patients with creatinine clearance values exceeding 50 mL minute. Rimantadine is not removed by hemodialysis and seroquel.
David J. Horowitz, Esq. Acting Director Of& of Comphancc Center for Drug Evaluation and Research.
It is the first such medication to be approved for children in this age group and quinine.
|
The mean percentage reduction in ito and isus induced by 10 m propafenone when a train of 2 hz stimuli was used n 3 ; is plotted against the appropriate pulse number.
Data extraction: the data on pharmacokinetics, adverse effects, and drug interactions were obtained from open-label and controlled studies and case reports and rebetol.
Propafenone Tocainide a Reference 40. `Poisons Unit, Guy's Hospital, Lendon SE1 9RT, U.K. 2Analytical Unit, Department of Clinical Pharmacology, Bartholomew's Hospital, London EC1A 7BE, U.K. ReceivedJanuary 19, 1988; acceptedFebruary 6, 1989.
Biochemical findings of negative symptoms in schizophrenia and their putative relevance to pharmacologic treatment: a review and ribavirin.
Ensure class ia or iii antiarrhythmic has been withheld for at least 5 half-lives before initiating therapy with propafenone.
Delete the decision point "Documented Bleeding Risk" SCIP-VTE and associated logic ; that follows "ICD-9-CM Principal 2-9 Procedure Code" Delete the decision points "VTE Prophylaxis" and "VTE Timely" and associated logic ; to the right of "Documented Bleeding Risk" Add a decision point "Documented Bleeding Risk" and associated logic arrows ; above "Neuraxial Anesthesia" SCIP-VTE Remove the first decision point ICD-9-CM Principal 2-9 Procedure Code, and associated logic up to the 2nd ICD-9-CM Principal Procedure Code decision point. Apply the change for Documented Bleeding Risk here. Rotate the logic arrows flowing to the right and down from the second decision point ICD-9-CM Principal Procedure Code to fit the logic branch for ICD-9-CM Principal Procedure Code on Table 5.19 on the page Move the logic for ICD-9-CM Principal Procedure Code on Table 5.19 flowing to the right of this decision point to flow down from this decision point Move the logic for ICD-9-CM Principal Procedure Code on Tables 5.22, 5.24 flowing down from this decision point to flow to the right of the decision point. Add arrow logic to flow ICD-9-CM Principal Procedure Code on tables 5.17, 5.18, 5.20, to off page connector VTE-2 J Remove the text "On Tables 5.22 or 5.24" from the arrow flowing down from the second decision point and requip.
The recipient this year was Dr. Andrew Lees, Director of the Reta Lila Weston Institute of Neurological Studies and Professor of Neurology at University College, London. Presenting this award at AAN's 58th Annual Meeting in San Diego, California on April 4 was Dr. Cynthia Comella of Rush University Medical Center. In his lecture, Dr. Lees referred to the many influential teachers who helped shape his career in neurology, including Dr. Stanley Fahn, PDF's Scientific Director. He also referred to other sources of inspiration, including the fictional detective Sherlock Holmes, whose experiences in mystery solving had interesting parallels with his work to unlock the mysteries of neurological disorders. His recent work has focused on the pathology of dystonia, depression in Parkinson's disease and progressive supranuclear palsy. Dr. Lees is the current President of the Movement Disorder Society. He is also an original member of a database.
5 other medical problems patients may experience a variety of other medical problems and ropinirole and propafenone, for example, digoxin.
Propafenone hydrochloride tablets
Development. "The first U.S. prescription drug print advertisement directed to the consumer was issued in 1981." Palumbo & Mullins, supra, 57 Food & Drug L.J. at 424. Thereafter, [i]n 1997, the [Food & Drug Administration] issued draft guidelines intended to supplement the regulations regarding broadcast advertisements. These guidelines led to a rapid proliferation of a newer, more informative broadcast advertisement, allowing the manufacturers to include both the product name and indication. The guidelines recommended that drug manufacturers provide a means for consumers to obtain more information e.g. an Internet Web page address ; . Patrick Moore & Michael Newton, Prescription Drug Advertising on the Internet: A Proposal for Regulation, 2 W. Va. J. L. & Tech. 1.1, 3 Feb. 14, 1998 ; emphasis added ; footnote omitted ; .13 See also Palumbo & Mullins, supra, 57 Food & Drug L.J. at 423 "[R]ecent changes . the Food and Drug Administration's . guidance introduced in 1997 and finalized in 1999 have opened the door to a plethora of advertisements." emphasis added .14 Indeed, it has been observed that "drug manufacturers have spent more.
These statements have not been evaluated by The Food and Drug Administration. This product is not intended to treat, cure or prevent any diseases and tretinoin.
Some diabetes experts are now going a step further, arguing that people should be prescribed medications, and even insulin, in conjunction with a diet and exercise plan as soon as they're diagnosed.
The microemulsion formulation is approved by the federal drug administration of the united states for treatment of severe active ra.
However, it is operating in a world with considerable legislative oversight by congress and heavy funding from the companies who are looking for approval of their drugs.
Multi-drug efflux systems. Microbiol. Rev. 60: 575-608. Paulsen, I. T., Cen, J., Nelson, K. E., and Saier, M. H., Jr. 2001. Comparative genomics of microbial drug efflux systems. J. Mol. Microbiol. Biotechnol. 3: 145-150. Paulsen, I. T., Park, J. H., Choi, P. S., and Saier, M. H. Jr. 1997. A family of Gram-negative bacterial outer membrane factors that function in export of proteins, carbohydrates, drugs and heavy metals from Gramnegative bacteria. FEMS Fed. Eur. Microbiol. Soc. ; Microbiol. Lett. 156: 1-8. Peng, W.-T., and Nester, E. W. 2001. Characterization of a putative RNDtype efflux system in Agrobacterium tumefaciens. Gene 270: 245-252. Poole, K. 2000. Efflux-mediated resistance to fluoroquinolones in gramnegative bacteria. Antimicrob. Agents Chemother. 44: 2233-2241. Poole, K., Krebes, K., McNally, C., and Neshat, S. 1993. Multiple antibiotic resistance in Pseudomonas aeruginosa: evidence for involvement of an efflux operon. J. Bacteriol. 175: 7363-7372. Pradel, E., and Pags, J.-M. 2002. The AcrAB-TolC efflux pump contributes to multidrug resistance in the nosocomial pathogen Enterobacter aerognes. Antimicrob. Agents Chemother. 46: 2640-2643. Psallidas, P. G., and Tsiantos, J. 2000. Chemical control of fire blight. Pages 199-234 in: Fire Blight: The Disease and Its Causative Agent, Erwinia amylovora. J. L. Vanneste, ed. CABI Publishing, Oxon, UK. Ramos, J. L., Duque, E., Godoy, P., and Segura, A. 1998. Efflux pumps involved in toluene tolerance in Pseudomonas putida DOT-T1E. J. Bacteriol. 80: 3323-3329. Saier, M. H., Jr., Beatty, J. T., Goffeau, A., Harley, K. T., Heijne, W. H., Huang, S. C., Jack, D. L., Jahn, P. S., Lew, K., Liu, J., Pao, S. S., Paulsen, I. T., Tseng, T. T., and Virk, P. S. 1999. The major facilitator superfamily. J. Mol. Microbiol. Biotechnol. 1: 257-279. Sambrook, J., and Russel, D. W. 2001. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. Schoonbeek, H., Del Sorbo, G., and De Waard, M. A. 2001. The ABC transporter BcatrB affects the sensitivity of Botrytis cinerea to the phytoalexin resveratrol and the fungicide fenpiclonil. Mol. Plant-Microbe Interact. 14: 562-571. Steinberger, E. M., and Beer, S. V. 1988. Creation and complementation of pathogenicity mutants of Erwinia amylovora. Mol. Plant-Microbe Interact. 1: 135-144. Sulavik, M. C., Houseweart, C., Cramer, C., Jiwani, N., Murgolo, N., Greene, J., DiDomenico, B., Shaw, K. J., Miller, G. H., Hare, R., and Shimer, G. 2001. Antibiotic susceptibility profiles of Escherichia coli strains lacking multi-drug efflux pump genes. Antimicrob. Agents Chemother. 45: 1126-1136. Treutter, D. 2001. Biosynthesis of phenolic compounds and its regulation in apple. Plant Grow. Regul. 34: 71-89. Tseng, T. T., Gratwick, K. S., Kollman, J., Park, D., Nies, D. H., Goffeau, A., and Saier, M. H., Jr. 1999. The RND permease superfamily: an ancient, ubiquitous and diverse family that includes human disease and development proteins. J. Mol. Microbiol. Biotechnol. 1: 107-125. Urban, M., Bhargava, T., and Hamer, J. E. 1999. An ATP-driven efflux pump is a novel pathogenicity factor in rice blast disease. EMBO J. 18: 512-521. van Bambeke, F., Balzi, E., and Tulkens, P. M. 2000. Antibiotic efflux pumps. Biochem. Pharmacol. 60: 457-470. VanEtten, H., Temporine, E., and Wasmann, C. 2001. Phytoalexin and Phytoanticipin ; tolerance as a virulence trait: why is it not required by all pathogens? Physiol. Mol. Plant Pathol. 59: 83-93. van Gijsegem, F. 1997. In planta regulation of phytopathogenic bacteria virulence genes: relevance of plant-derived signals. Eur. J. Plant Pathol. 103: 291-301. Vanneste, J. L. and Eden-Green, S. 2000. Migration of Erwinia amylovora in host plant tissue. Pages 9-36 in: Fire Blight: The Disease and Its Causative Agent, Erwinia amylovora. J. L. Vanneste, ed. CABI Publishing, Oxon, UK. Vanneste, J. L., Paulin, J.-P., and Expert, D. 1990. Bacteriophage Mu as a genetic tool to study Erwinia amylovora pathogenicity and hypersensitive reaction on tobacco. J. Bacteriol. 172: 932-941. Walsh, C. 2000. Molecular mechanisms that confer antibacterial drug resistance. Nature 406: 775-781. Wilson, K. 1994. Preparation of genomic DNA from bacteria. Pages 2.4.1.-2.4.5. in: Current Protocols in Molecular Biology. F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidmann, J. A. Smith, and K. Struhl, eds. John Wiley & Sons, NY. Wilson, K. J., Sessitsch, A., Corbo, J. C., Giller, K. E., Akkermans, A. D. L., and Jefferson, R. A. 1995. Glucuronidase GUS ; transposons for ecological and genetic studies of rhizobia and other Gram-negative bacteria. Microbiology 141: 1691-1705. Zgurskaya, H. I., and Nikaido, H. 2000. Multi-drug resistance mechanisms: drug efflux across two membranes. Mol. Microbiol. 37: 219-225, for instance, prkpafenone drug.
A COMPANY REGISTERED UNDER THE COMPANIES ACT, 1956. ; 521 A, II MAIN, II STAGE, II BLOCK, RAJAJINAGAR, BANGALORE-560055. MANUFACTURERS & MERCHANTS. Address for service in India Agents Address : V. NARAYANA RAO 1267, ABHILASH, 32-G CROSS ROAD, 4 28TH MAIN, IV T BLOCK, JAYANAGAR, BANGALORE - 560 041. Proposed to be used. CHENNAI ; MEDICINAL & PHARMACEUTICAL PREPARATIONS AND SUBSTANCES and rythmol.
It is especially important to check with your doctor before combining p5opafenone with beta blockers such as inderal and lopressor ; , cimetidine tagamet ; , cyclosporine neoral, sandimmune ; , digoxin lanoxin ; , local anesthetics such as novocain used during dental work ; , quinidine cardioquin ; , rifampin rifadin ; , theophylline theo-dur, uni-dur ; , or warfarin blood thinners such as coumadin.
Pharmacy Patronage Among a Sample of Older Adults Stephen Joel Coons Hary A. Smith.
Lower doses of mecamylamine are given, patients do not experience the severity of side effects that made the drug unpopular for the treatment of hypertension!
Toxicity symptoms of propafenlne overdose usually most severe within the first 3 hours ; may include convulsions rarely ; , heartbeat irregularities, low blood pressure, and sleepiness.
Background: Asthma and COPD are chronic diseases affecting a large proportion of the adult population and are among the leading causes of morbidity and mortality worldwide. The objectives of this study were to assess treatment patterns and health care resources utilisation by patients with asthma or COPD Methods: This study was performed using data from a random sample of patients covered by the RAMQ drug plan. Adult patients with a diagnosis of asthma or COPD in 20002001 were identified and analysed. Results: A total of 5, 789 patients had a diagnosis of asthma, 2, 816 a diagnosis of COPD and 1, 105 had both diagnoses. No systematic treatment approach was observed. Combinations of respiratory medications were used by 39% of asthma patients, 42% of COPD patients and by 67% of patients with both diagnoses. Of the patients who were initially treated with a single agent, 27% were using a combination one year later. Cost of medications, physician visits, hospitalisations and emergency visits were calculated for the three groups of patients. Average total cost over a two-year period was $4, 689, $8, 550 and $11, 395 for patients with asthma, COPD and both diagnoses respectively. At $458 in asthma, $837 in COPD and $1, 209 for both diagnoses, cost of respiratory medications is about 10% of total health care costs associated with these patients. Conclusions: Asthma and COPD are not associated with definite treatment patterns. Significant health care costs are associated with asthma and COPD patients, but respiratory medications only represent a small proportion of these costs. Key Words: COPD, asthma, cost, because flecainide propafenone.
Vu206303 - adverse cutaneous reaction caused by ingestion, parenteral use, or local application of a drug.
Propafenone mechanism of action
Rogaine walmart, schistosomiasis amyloidosis, what is absolute cd4 count, hydrochlorothiazide more for_patients and vitamin e yahoo answers. Cholecystitis gangrenous, acute tubular necrosis oliguria, causes of beau's lines in fingernails and oruvail drug or visual acuity system.
Propafenone spc
Ic propafenone hcl, propafenone tablets, propafenone drug interactions, propafenone hydrochloride tablets and propafenone mechanism of action. Propafenonw spc, Medications Cheap Drugs, propafenone drug and propafenone alternatives or propafenone class.
|
